Moxonidine for Prevention of Post-ablation AFib Recurrences

NCT01791699 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Moxonidine
DRUG: Placebo

Sponsor

Spyridon Deftereos